Novo Nordisk's analog insulin will be sold cheaply in Walmart

Novo Nordisk will produce an insulin analog for the retail giant Walmart, which will be offering the drug at far lower prices than competing drugs for patients without insurance.

US retail giant Walmart will soon be selling its own brand of analog insulin, which will be produced by Novo Nordisk, according to Bloomberg News.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading